Niagen Bioscience (NAGE) Proxy filing summary

Executive summary

• The annual meeting is scheduled for June 24, 2026, with voting on director elections, auditor ratification, and executive compensation advisory approval.

• Stockholders of record as of April 27, 2026, are eligible to vote, with materials distributed primarily via internet access.

• The board recommends voting in favor of all proposals, including the election of eight director nominees and the ratification of Crowe LLP as auditor.

Voting matters and shareholder proposals

• Three main proposals: election of eight directors, ratification of Crowe LLP as auditor for 2026, and advisory approval of executive compensation.

• Board recommends voting FOR all proposals.

• Shareholders may submit proposals for the 2027 meeting between March 26 and April 25, 2027.

Board of directors and corporate governance

• Board consists of eight nominees, including six independent directors, one officer, and one affiliated director.

• Board committees: Audit, Compensation, and Nominating and Corporate Governance, all with independent chairs.

• Corporate governance documents, including the Code of Conduct, are available online.

• Board leadership includes an affiliated Chairman and a Lead Independent Director.

• Annual board and committee self-evaluations are conducted.